Clinical Staphylococcus aureus inhibits human T-cell activity through interaction with the PD-1 receptor
Open Access
- 31 October 2023
- journal article
- research article
- Published by American Society for Microbiology in mBio
- Vol. 14 (5) , e0134923
Abstract
Staphylococcus aureus ( S. aureus ) represents a major clinical challenge due to its explicit capacity to select mutations that increase antibiotic resistance and immune evasion. However, the molecular mechanisms are poorly defined, especially for adaptive immunity. Cancer immunotherapy targeting programmed cell death protein 1 (PD-1) enhances T-cell activity and is emerging for the treatment of certain viral infections, while its potential against bacterial infections remains elusive. We show that an S. aureus clpP mutant, selected during clinical antibiotic therapy, inhibits T-cell activity by directly interacting with PD-1 on human T cells. Specificity of the interaction was confirmed using recombinant PD-1, as well as PD-1 overexpressing and knock out cells. Moreover, the PD-1-binding S. aureus inhibited intracellular calcium mobilization, T-cell proliferation, CD25 expression, and IL-2 secretion, while the key effects were alleviated by antibody-mediated PD-1 blockade using an engineered IgG1-based anti-PD-1 antibody. Our results suggest that clpP mutant S. aureus directly targets PD-1 to evade immune activation and that therapeutic targeting of PD-1 may be used against certain staphylococcal infections. IMPORTANCE: Therapies that target and aid the host immune defense to repel cancer cells or invading pathogens are rapidly emerging. Antibiotic resistance is among the largest threats to human health globally. Staphylococcus aureus ( S. aureus ) is the most common bacterial infection, and it poses a challenge to the healthcare system due to its significant ability to develop resistance toward current available therapies. In long-term infections, S. aureus further adapt to avoid clearance by the host immune defense. In this study, we discover a new interaction that allows S. aureus to avoid elimination by the immune system, which likely supports its persistence in the host. Moreover, we find that blocking the specific receptor (PD-1) using antibodies significantly relieves the S. aureus -imposed inhibition. Our findings suggest that therapeutically targeting PD-1 is a possible future strategy for treating certain antibiotic-resistant staphylococcal infections.Keywords
Funding Information
- Faculty of Health and Medical Sciences, University of Copenhagen (Ph.D. Scholarship A3507)
- Else og Mogens Wedell Wedellsborgs Fond (Grant 3A-17-1)
- Sundhed og Sygdom, Det Frie Forskningsråd (DFF-6111-00499)
- Novo Nordisk Fonden (NNF15CC0018346)
- Novo Nordisk Fonden (NNF20SA0066621, NNF19SA0035474, NNF19SA0056783, NNF21SA0072683)
- the National Health and Medical Research Council Australia (GNT1196103)
- the National Health and Medical Research Council Australia (GNT1194325)
This publication has 73 references indexed in Scilit:
- A Genetic Resource for Rapid and Comprehensive Phenotype Screening of Nonessential Staphylococcus aureus GenesmBio, 2013
- Control of Adaptive Immune Responses by Staphylococcus aureus through IL-10, PD-L1 and TLR2Scientific Reports, 2012
- Programmed cell death 1 forms negative costimulatory microclusters that directly inhibit T cell receptor signaling by recruiting phosphatase SHP2Journal of Experimental Medicine, 2012
- walK and clpP Mutations Confer Reduced Vancomycin Susceptibility in Staphylococcus aureusAntimicrobial Agents and Chemotherapy, 2011
- Comparative Genome Sequencing of an Isogenic Pair of USA800 Clinical Methicillin-Resistant Staphylococcus aureus Isolates Obtained before and after Daptomycin Treatment FailureAntimicrobial Agents and Chemotherapy, 2011
- Programmed death-1 (PD-1)–deficient mice are extraordinarily sensitive to tuberculosisProceedings of the National Academy of Sciences, 2010
- Community-acquired bloodstream infections in Africa: a systematic review and meta-analysisThe Lancet Infectious Diseases, 2010
- T Cell ActivationAnnual Review of Immunology, 2009
- Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infectionNature Immunology, 2008
- Blockade of endogenous B7‐H1 suppresses antibacterial protection after primary Listeria monocytogenes infectionImmunology, 2007